The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
about
The Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human CancerPathways for repairing and tolerating the spectrum of oxidative DNA lesionsThe cerebro-morphological fingerprint of a progeroid syndrome: white matter changes correlate with neurological symptoms in xeroderma pigmentosumTranscription-coupled DNA repair: two decades of progress and surprisesReal-time quantification of Xeroderma pigmentosum mRNA from the mammalian cochlea.Evidence of ultraviolet type mutations in xeroderma pigmentosum melanomas.Unexpected occurrence of xeroderma pigmentosum in an uncle and nephew.An Xpb mouse model for combined xeroderma pigmentosum and cockayne syndrome reveals progeroid features upon further attenuation of DNA repair.The 8,5'-cyclopurine-2'-deoxynucleosides: candidate neurodegenerative DNA lesions in xeroderma pigmentosum, and unique probes of transcription and nucleotide excision repair.Five novel mutations in the ADAR1 gene associated with dyschromatosis symmetrica hereditaria.The role of XPC: implications in cancer and oxidative DNA damageDNA repair deficiency in neurodegeneration.Mitochondrial reactive oxygen species are scavenged by Cockayne syndrome B protein in human fibroblasts without nuclear DNA damageEndogenous formation and repair of oxidatively induced G[8-5 m]T intrastrand cross-link lesion.Dynamic compartmentalization of DNA repair proteins within spiral ganglion neurons in response to noise stress.Oxidative DNA damage and nucleotide excision repair.Elements That Regulate the DNA Damage Response of Proteins Defective in Cockayne SyndromeImpact of age-associated cyclopurine lesions on DNA repair helicases.Blinded by the UV light: how the focus on transcription-coupled NER has distracted from understanding the mechanisms of Cockayne syndrome neurologic diseaseExposure to mitochondrial genotoxins and dopaminergic neurodegeneration in Caenorhabditis elegansActive transcriptomic and proteomic reprogramming in the C. elegans nucleotide excision repair mutant xpa-1.Slow accumulation of mutations in Xpc-/- mice upon induction of oxidative stress.Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease.Chemical and structural characterization of interstrand cross-links formed between abasic sites and adenine residues in duplex DNA.Xeroderma pigmentosum: low prevalence of germline XPA mutations in a Brazilian XP population.Mitochondrial dynamics and autophagy aid in removal of persistent mitochondrial DNA damage in Caenorhabditis elegans.Noise Stress Induces an Epidermal Growth Factor Receptor/Xeroderma Pigmentosum-A Response in the Auditory Nerve.Do all of the neurologic diseases in patients with DNA repair gene mutations result from the accumulation of DNA damage?The involvement of DNA-damage and -repair defects in neurological dysfunctionThe oxidatively induced DNA lesions 8,5'-cyclo-2'-deoxyadenosine and 8-hydroxy-2'-deoxyadenosine are strongly resistant to acid-induced hydrolysis of the glycosidic bondComprehensive Assessment of Oxidatively Induced Modifications of DNA in a Rat Model of Human Wilson's DiseaseCharacterization of Interstrand DNA-DNA Cross-Links Derived from Abasic Sites Using Bacteriophage ϕ29 DNA Polymerase.The role of Cockayne Syndrome group B (CSB) protein in base excision repair and aging.Brain capacity for repair of oxidatively damaged DNA and preservation of neuronal function.The influence of DNA repair on neurological degeneration, cachexia, skin cancer and internal neoplasms: autopsy report of four xeroderma pigmentosum patients (XP-A, XP-C and XP-D).Tissue-specific accelerated aging in nucleotide excision repair deficiencyAccumulation of (5'S)-8,5'-cyclo-2'-deoxyadenosine in organs of Cockayne syndrome complementation group B gene knockout mice.Persistent transcription-blocking DNA lesions trigger somatic growth attenuation associated with longevityXeroderma pigmentosum-Cockayne syndrome complex.Purine 5',8-cyclonucleoside lesions: chemistry and biology.
P2860
Q26801375-DE5CAF9B-33C4-462C-8733-DE4634FD513BQ26992194-F56AFB48-4243-41BE-87AC-FC0ADC19E938Q28731899-0A8FF023-D651-4CF8-A93D-9003FB4FFF0FQ29614662-E4D662D3-8C39-449F-BDAC-B6F49DF878EAQ30473910-660B3336-C98F-4EBE-A121-024BD4A7348CQ30487052-95F3040C-F491-4F6B-93B5-0BE4E63E62C8Q30887050-896605D9-A4E3-4F4D-9263-8EEE18CB8309Q33396433-C32E1309-9077-4C4D-A56E-17C433171DDBQ33554002-F70E9D90-4258-4D9B-B4B5-3D800E201759Q33927121-48453C9D-95A8-427A-B249-2ED2864B68C1Q33962926-04B1DC9F-43EB-4F51-9816-1DA0E0DC71AFQ34183328-A214DDCF-F0B8-4A29-B0A7-C5E87640BD58Q34218129-770524D2-8D80-4101-A4AC-F7402367DFE9Q34267490-9DC793BE-9D9A-4AFD-A0A7-AF7B3D92C1C2Q34382866-224FFA51-FDE4-4B2A-BD53-D863D37C0B61Q34502142-19E40811-436F-4A60-BFA8-FA839188D89EQ34503412-11612E71-B913-4925-A3AD-3BC85C594786Q34542484-E33444FD-E860-4B71-B00B-E38965D38505Q34554610-0E62BD24-CB40-467B-A056-174E98D7E6E4Q34653802-F1E49F1C-6BA9-40A3-AB5C-DC198230805EQ34666406-730F879A-93A2-4336-9567-D88DF88750C3Q35003893-FFEB2487-2044-48F1-A111-569C863CEDD7Q35470522-595EE4E2-F23B-49BA-8A81-3517B4BD7020Q35476294-23278289-B6F0-407A-B952-87F5742F3FA0Q35585765-D927976E-A1FC-4CF6-AF14-984ED9E0F411Q36228588-A2F95D0B-E91F-4F24-AD4B-60370035D788Q36240553-6D95DB1C-6D68-4B9B-A2EF-078202EE4BF8Q36690915-789C60F9-F814-4675-A0EB-5510C8C469FFQ36718848-81828C10-ECF7-4FB4-B638-63813DE6D57BQ36724897-C247AD5F-16E2-4428-AC89-6AA2E8DD8A90Q36745140-21506A37-F9A0-454E-80AF-1BC22FD2DF8AQ36784150-71AFA61E-D821-4E2E-993C-B6341C2C67A4Q36882150-3D6F873A-34B4-44A9-818B-1EAD1F2A7761Q37122200-B61AC878-5359-47D4-9EAD-2CAB02DAAA32Q37180228-01762FAF-F2C9-4E75-8A53-9F261DC78CB1Q37185712-09815DF6-CDA0-4A42-9FB0-ED8F0FDE5548Q37219471-A56620B5-458F-4352-B874-C23E40E459F6Q37434964-CD8A848E-D278-480C-AA3F-B28152F0A0A7Q37736827-2CB126FE-31BA-46B9-9596-027592264957Q37827361-6E9BF02E-2245-4D95-B9EB-17286D03DD6C
P2860
The case for 8,5'-cyclopurine-2'-deoxynucleosides as endogenous DNA lesions that cause neurodegeneration in xeroderma pigmentosum.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@ast
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@en
type
label
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@ast
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@en
prefLabel
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@ast
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@en
P2860
P1433
P1476
The case for 8,5'-cyclopurine- ...... tion in xeroderma pigmentosum.
@en
P2093
P J Brooks
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2006.10.025
P407
P577
2006-12-19T00:00:00Z